...
首页> 外文期刊>Chirality: The pharmacological, biological, and chemical consequences of molecular asymmetry >Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies
【24h】

Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies

机译:含新氟的手性酰肼 - 腙:设计,合成,结构阐明,抗氧化剂和抗胆碱酯酶活性,以及硅研究

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, a series of fluorine-containing chiral hydrazide-hydrazone derivatives [III-XII] from x29f;-cysteine ethyl ester hydrochloride was synthesized as new antioxidant and anticholinesterase agents. The antioxidant activity of these derivatives was evaluated by ABTS(+center dot) and DPPH center dot scavenging and CUPRAC assays and the anticholinesterase activity by the Ellman method spectrophotometrically. The results of the antioxidant assay showed that compounds V, IX, and X exhibited higher activity than BHT and alpha-tocopherol used as positive standards. Among the synthesized derivatives, compound IX (IC50: 2.3 +/- 1.6 mu M) exhibited higher acetylcholinesterase inhibitory activity than galantamine (IC50: 4.5 +/- 0.8 mu M). Compounds XI (IC50: 9.6 +/- 1.0 mu M), IX (IC50: 12.5 +/- 1.6 mu M), III (IC50: 16.0 +/- 1.6 mu M), X (IC50: 17.2 +/- 1.8 mu M), VI (IC50: 20.2 +/- 0.8 mu M), XII (IC50: 21.5 +/- 1.0 mu M), and VII (IC50: 24.6 +/- 0.6 mu M) displayed better butyrylcholinesterase inhibitory activity than galantamine (IC50: 46.03 +/- 0.14 mu M). ADME-Tox analysis was used to probe the drug-like properties of the compounds. Molecular docking studies were also applied to understand the interactions between compounds and targets. The docking calculations were supported by the experimental data. In particular, compound IX, having better activity than galantamine against acetylcholinesterase and butyrylcholinesterase enzymes, was visualized using molecular docking.
机译:在该研究中,来自X29F的一系列含氟手性酰肼 - 腙衍生物[III-XII]; - 盐酸盐乙酯盐酸盐作为新的抗氧化剂和抗胆碱酯酶试剂合成。通过ABTS(+中心点)和DPPH中心点清除和CupracessaseSays分光光度法评估这些衍生物的抗氧化活性。抗氧化测定的结果表明,化合物V,IX和X表现出比使用的BHT和α-生育酚作为阳性标准的活性更高。在合成的衍生物中,化合物IX(IC 50:2.3 +/-1.6μm)表现出高于加兰汀(IC50:4.5 +/-0.8μm)的乙酰胆碱酯酶抑制活性。化合物XI(IC50:9.6 +/- 1.0 mu m),IX(IC50:12.5 +/- 1.6 mu m),III(IC50:16.0 +/- 1.6 mu m),x(IC50:17.2 +/- 1.8亩M),VI(IC50:20.2 +/- 0.8 mu m),XII(IC 50:21.5 +/- 1.0 mu m),和VII(IC 50:24.6 +/- 0.6 mu m)显示比加兰蒽醌更好的丁酰胆碱酯酶抑制活性( IC50:46.0​​3 +/- 0.14 mu m)。 Adme-Tox分析用于探测化合物的药物状性质。分子对接研究也应用于了解化合物和靶之间的相互作用。基于实验数据支持对接计算。特别地,使用分子对接可视化具有比加乙酰胆碱酯酶和丁酰基胆碱酯酶和丁酰基胆碱酯酶酶的更好活性的化合物IX。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号